Article Details
Retrieved on: 2024-07-21 20:56:07
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
CureVac said its COVID-19 vaccine was 48% effective in the final analysis of its pivotal mass trial, only marginally better than the 47% reported ...
Article found on: ca.sports.yahoo.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here